Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart (Q44345772)

2 December 2017

title

Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart (English)

1 reference

2 December 2017

1 reference

Josef Margreiter

1

1 reference

2 December 2017

Markus Mittermayr

2

1 reference

2 December 2017

Johannes Mair

3

1 reference

2 December 2017

Angelika Hammerer-Lercher

4

1 reference

2 December 2017

Jordan Kountchev

5

1 reference

2 December 2017

Anton Klingler

6

1 reference

2 December 2017

Wolfgang Schobersberger

7

1 reference

2 December 2017

publication date

1 November 2002

1 reference

2 December 2017

1 reference

2 December 2017

volume

108

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

249-255

1 reference

Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1 alpha in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Iloprost Inhibits Neutrophil-induced Lung Injury and Neutrophil Adherence to Endothelial Monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Stimulation of pulmonary big endothelin-1 and endothelin-1 by antithrombin III: a rationale for combined application of antithrombin III and endothelin antagonists in sepsis-related acute respiratory distress syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Protective effects of antithrombin III supplementation on warm ischemia and reperfusion injury in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Effect of prostaglandins I2 (prostacyclin) and F2 alpha on function, energy metabolism, and calcium uptake in ischaemic/reperfused hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Inhibition of post-ischemic ventricular recovery by low concentrations of prostacyclin in isolated working rat hearts: dependency on concentration, ischemia duration, calcium and relationship to myocardial energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Inotropic actions of eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900031-8

7 January 2021

10.1016/S0049-3848(03)00031-8

Identifiers

DOI

1 reference

2 December 2017

1 reference